Geoffrey M. Parker is CHIEF FINANCIAL OFFICER of Allogene Therapeutics, Inc.. Currently has a direct ownership of 1.3 Million shares of ALLO, which is worth approximately $2.82 Million. The most recent transaction as insider was on Feb 03, 2025, when has been sold 4,361 shares (Common Stock) at a price of $1.73 per share, resulting in proceeds of $7,544. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.3M
14.98% 3M change
58.8% 12M change
Total Value Held $2.82 Million

Geoffrey M. Parker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2025
SELL
Open market or private sale
$7,544 $1.73 p/Share
4,361 Reduced 0.33%
1,301,540 Common Stock
Jan 24 2025
BUY
Grant, award, or other acquisition
-
173,913 Added 11.75%
1,305,901 Common Stock
Oct 21 2024
SELL
Payment of exercise price or tax liability
$103,387 $2.84 p/Share
36,404 Reduced 3.12%
1,131,988 Common Stock
May 16 2024
BUY
Grant, award, or other acquisition
$1,000,001 $2.9 p/Share
344,828 Added 22.85%
1,164,418 Common Stock
Jan 30 2024
BUY
Open market or private purchase
$684 $3.6 p/Share
190 Added 0.02%
819,590 Common Stock
Jan 25 2024
BUY
Grant, award, or other acquisition
-
29,400 Added 3.46%
819,400 Common Stock
Oct 16 2023
BUY
Grant, award, or other acquisition
-
790,000 Added 50.0%
790,000 Common Stock

Also insider at

TCDA
Tricida, Inc. Healthcare
CCXI
ChemoCentryx, Inc.
PRGO
PERRIGO Co plc Healthcare
BTTX
Better Therapeutics, Inc. Healthcare
GMP

Geoffrey M. Parker

CHIEF FINANCIAL OFFICER
San Carlos, CA

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if
Any

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Allogene Therapeutics, Inc.

Track Activities on ALLO